![Anthony H. Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony H. Williams
Plus aucun poste en cours
Historique de carrière de Anthony H. Williams
Anciens postes connus de Anthony H. Williams
Sociétés | Poste | Début | Fin |
---|---|---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Directeur Technique/Scientifique/R&D | 12/04/2007 | - |
DYAX CORP. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Anthony H. Williams
University of Cambridge | Undergraduate Degree |
University College London | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Royaume-Uni | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Dyax Corp.
![]() Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Anthony H. Williams
- Expérience